PYC completed critical tolerability and safety studies in non-human primates – Results are expected in the near future once the histopathology analysis is complete
....at the point when funding and partnering contract is finalised.
My guess is that those completed studies were all what was needed to progress on partnering activities.
Very close now
all IMO
Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-3
-
- There are more pages in this discussion • 6 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PYC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
14.0¢ |
Change
0.010(7.69%) |
Mkt cap ! $653.2M | |||
| Open | High | Low | Value | Volume |
| 14.0¢ | 14.5¢ | 13.0¢ | $1.446M | 10.38M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 252759 | 13.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 14.0¢ | 113762 | 2 |
View Market Depth
| Last trade - 16.10pm 30/08/2024 (20 minute delay) ? |
| PYC (ASX) Chart |